Citations (110)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Sadegh Ghaderi, Farzad Fatehi, Sanjay Kalra & Seyed Amir Hossein Batouli. (2023) MRI biomarkers for memory-related impairment in amyotrophic lateral sclerosis: a systematic review. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24:7-8, pages 572-588.
Read now
Read now
. (2021) Theme 03 - IN VITRO EXPERIMENTAL MODELS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:sup2, pages 58-72.
Read now
Read now
Kate T. Brizzi, John F. P. Bridges, Jill Yersak, Calaneet Balas, Neil Thakur, Miriam Galvin, Orla Hardiman, Chad Heatwole, John Ravits, Zachary Simmons, Lucie Bruijn, James Chan, Richard Bedlack & James D. Berry. (2020) Understanding the needs of people with ALS: a national survey of patients and caregivers. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:5-6, pages 355-363.
Read now
Read now
Filippo Baldacci, Sonia Mazzucchi, Alessandra Della Vecchia, Linda Giampietri, Nicola Giannini, Maya Koronyo-Hamaoui, Roberto Ceravolo, Gabriele Siciliano, Ubaldo Bonuccelli, Fanny M. Elahi, Andrea Vergallo, Simone Lista, Filippo Sean Giorgi & Harald Hampel. (2020) The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases. Expert Review of Molecular Diagnostics 20:4, pages 421-441.
Read now
Read now
William Huynh, Rebekah Ahmed, Colin J. Mahoney, Chilan Nguyen, Sicong Tu, Jashelle Caga, Patricia Loh, Cindy S-Y Lin & Matthew C. Kiernan. (2020) The impact of cognitive and behavioral impairment in amyotrophic lateral sclerosis. Expert Review of Neurotherapeutics 20:3, pages 281-293.
Read now
Read now
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2019) Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 53-60.
Read now
Read now
Jashelle Caga, Sharpley Hsieh, Elizabeth Highton-Williamson, Margaret C. Zoing, Eleanor Ramsey, Emma Devenney, Rebekah M. Ahmed, Anne Hogden & Matthew C. Kiernan. (2018) The burden of apathy for caregivers of patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:7-8, pages 599-605.
Read now
Read now
Michael J. Strong, Sharon Abrahams, Laura H. Goldstein, Susan Woolley, Paula Mclaughlin, Julie Snowden, Eneida Mioshi, Angie Roberts-South, Michael Benatar, Tibor HortobáGyi, Jeffrey Rosenfeld, Vincenzo Silani, Paul G Ince & Martin R. Turner. (2017) Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:3-4, pages 153-174.
Read now
Read now
Venkateswaran Rajagopalan & Erik P. Pioro. (2014) Distinct patterns of cortical atrophy in ALS patients with or without dementia: An MRI VBM study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:3-4, pages 216-225.
Read now
Read now
Chiara Cerami, Alessandra Dodich, Nicola Canessa, Chiara Crespi, Sandro Iannaccone, Massimo Corbo, Christian Lunetta, Monica Consonni, Elisa Scola, Andrea Falini & Stefano F. Cappa. (2014) Emotional empathy in amyotrophic lateral sclerosis: a behavioural and voxel-based morphometry study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:1-2, pages 21-29.
Read now
Read now
Clare Carmichael & Patrick Carmichael. (2014) BNCI systems as a potential assistive technology: ethical issues and participatory research in the BrainAble project. Disability and Rehabilitation: Assistive Technology 9:1, pages 41-47.
Read now
Read now
Anne Hogden, David Greenfield, Peter Nugus & Matthew C Kiernan. (2012) Engaging in patient decision-making in multidisciplinary care for amyotrophic lateral sclerosis: the views of health professionals. Patient Preference and Adherence 6, pages 691-701.
Read now
Read now
Matthew J. Murphy, Gloria M. Grace, Maria C. Tartaglia, J. B. Orange, Xiaogang Chen, Ann Rowe, Karen Findlater, Roman I. Kozak, Morris Freedman, Ting-Yim Lee & Michael J. Strong. (2012) Widespread cerebral haemodynamics disturbances occur early in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 13:2, pages 202-209.
Read now
Read now
Wencheng Yang & Michael J. Strong. (2012) Widespread neuronal and glial hyperphosphorylated tau deposition in ALS with cognitive impairment. Amyotrophic Lateral Sclerosis 13:2, pages 178-193.
Read now
Read now
Ali Aamer Habib & Hiroshi Mitsumoto. (2011) Emerging drugs for amyotrophic lateral sclerosis. Expert Opinion on Emerging Drugs 16:3, pages 537-558.
Read now
Read now
Susan C. Woolley, Yu Zhang, Norbert Schuff, Michael W. Weiner & Jonathan S. Katz. (2011) Neuroanatomical correlates of apathy in ALS using 4 Tesla diffusion tensor MRI. Amyotrophic Lateral Sclerosis 12:1, pages 52-58.
Read now
Read now
Joe Senda, Shigenori Kato, Tomotsugu Kaga, Mizuki Ito, Naoki Atsuta, Tomohiko Nakamura, Hirohisa Watanabe, Fumiaki Tanaka, Shinji Naganawa & Gen Sobue. (2011) Progressive and widespread brain damage in ALS: MRI voxel-based morphometry and diffusion tensor imaging study. Amyotrophic Lateral Sclerosis 12:1, pages 59-69.
Read now
Read now
Lidia Cova & Vincenzo Silani. (2010) Amyotrophic lateral sclerosis: applications of stem cells – an update. Stem Cells and Cloning: Advances and Applications 3, pages 145-156.
Read now
Read now
Susan C. Woolley, Dan H. Moore & Jonathan S. Katz. (2010) Insight in ALS: Awareness of behavioral change in patients with and without FTD. Amyotrophic Lateral Sclerosis 11:1-2, pages 52-56.
Read now
Read now
Donald R Staines, Ekua W Brenu & Sonya Marshall-Gradisnik. (2009) Postulated vasoactive neuropeptide immunopathology affecting the blood–brain/blood–spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?. Neuropsychiatric Disease and Treatment 5, pages 81-89.
Read now
Read now
Michael J. Strong, Gloria M. Grace, Morris Freedman, Cathy Lomen-Hoerth, Susan Woolley, Laura H. Goldstein, Jennifer Murphy, Christen Shoesmith, Jeffery Rosenfeld, P. Nigel Leigh, Lucie Bruijn, Paul Ince & Denise Figlewicz. (2009) Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 10:3, pages 131-146.
Read now
Read now
Articles from other publishers (89)
Cameron G. Thomson, Paul R. Hutchinson & Peter J. Stern. (2023) Misdiagnosis in Amyotrophic Lateral Sclerosis. The Journal of Hand Surgery 48:8, pages 822-826.
Crossref
Crossref
Li Ma, Chen Liang, Jing Wang, Qing Chang, Yuan Wang, Wei Zhang, Yuanning Du, Jotham Sadan & Jian-Fu Chen. (2023) Reversing lysosome-ribosome circuit dysregulation mitigates C9FTD/ALS neurodegeneration and behaviors. Human Molecular Genetics 32:8, pages 1252-1265.
Crossref
Crossref
Sara Cappelli, Alida Spalloni, Fabian Feiguin, Giulia Visani, Urša Šušnjar, Anna-Leigh Brown, Hemali Phatnani, Justin Kwan, Dhruv Sareen, James R Broach, Zachary Simmons, Ximena Arcila-Londono, Edward B Lee, Vivianna M Van Deerlin, Neil A Shneider, Ernest Fraenkel, Lyle W Ostrow, Frank Baas, Noah Zaitlen, James D Berry, Andrea Malaspina, Pietro Fratta, Gregory A Cox, Leslie M Thompson, Steve Finkbeiner, Efthimios Dardiotis, Timothy M Miller, Siddharthan Chandran, Suvankar Pal, Eran Hornstein, Daniel J MacGowan, Terry Heiman-Patterson, Molly G Hammell, Nikolaos. A Patsopoulos, Oleg Butovsky, Joshua Dubnau, Avindra Nath, Robert Bowser, Matt Harms, Eleonora Aronica, Mary Poss, Jennifer Phillips-Cremins, John Crary, Nazem Atassi, Dale J Lange, Darius J Adams, Leonidas Stefanis, Marc Gotkine, Robert H Baloh, Suma Babu, Towfique Raj, Sabrina Paganoni, Ophir Shalem, Colin Smith, Bin Zhang, Brent Harris, Iris Broce, Vivian Drory, John Ravits, Corey McMillan, Vilas Menon, Marco De Bardi, Giovanna Borsellino, Maria Secrier, Hemali Phatnani, Maurizio Romano, Pietro Fratta, Patrizia Longone & Emanuele Buratti. (2022) NOS1AP is a novel molecular target and critical factor in TDP-43 pathology. Brain Communications 4:5.
Crossref
Crossref
Miguel A. Rubio, Mireia Herrando-Grabulosa, Roser Velasco, Israel Blasco, Monica Povedano & Xavier Navarro. (2022) TDP-43 Cytoplasmic Translocation in the Skin Fibroblasts of ALS Patients. Cells 11:2, pages 209.
Crossref
Crossref
Jiahui Tang, Yuan Yang, Zhenxiang Gong, Zehui Li, Lifang Huang, Fengfei Ding, Mao Liu & Min Zhang. (2021) Plasma Uric Acid Helps Predict Cognitive Impairment in Patients With Amyotrophic Lateral Sclerosis. Frontiers in Neurology 12.
Crossref
Crossref
Pavlína Hemerková & Martin Vališ. (2021) Role of Oxidative Stress in the Pathogenesis of Amyotrophic Lateral Sclerosis: Antioxidant Metalloenzymes and Therapeutic Strategies. Biomolecules 11:3, pages 437.
Crossref
Crossref
Andrew Eisen. (2021) The Dying Forward Hypothesis of ALS: Tracing Its History. Brain Sciences 11:3, pages 300.
Crossref
Crossref
Rebekah M. Ahmed, Frederik Steyn & Luc Dupuis. 2021. The Human Hypothalamus - Middle and Posterior Region. The Human Hypothalamus - Middle and Posterior Region
327
338
.
Rebekah M. Ahmed, Glenda Halliday & John R. Hodges. 2021. The Human Hypothalamus: Neuropsychiatric Disorders. The Human Hypothalamus: Neuropsychiatric Disorders
269
280
.
Rebekah M. Ahmed, John R. Hodges & Olivier Piguet. 2021. Frontotemporal Dementias. Frontotemporal Dementias
1
15
.
Caroline Gertrud Bergner, Christiane Michaela Neuhofer, Claudia Funke, Saskia Biskup, Philipp von Gottberg, Claudia Bartels, Jan Christoph Koch & Katrin Radenbach. (2020) Case Report: Association of a Variant of Unknown Significance in the FIG4 Gene With Frontotemporal Dementia and Slowly Progressing Motoneuron Disease: A Case Report Depicting Common Challenges in Clinical and Genetic Diagnostics of Rare Neuropsychiatric and Neurologic Disorders. Frontiers in Neuroscience 14.
Crossref
Crossref
Pooja Shree Mishra, Hejer Boutej, Geneviève Soucy, Christine Bareil, Sunny Kumar, Vincent Picher-Martel, Nicolas Dupré, Jasna Kriz & Jean-Pierre Julien. (2020) Transmission of ALS pathogenesis by the cerebrospinal fluid. Acta Neuropathologica Communications 8:1.
Crossref
Crossref
Michael J. Strong, Neil S. Donison & Kathryn Volkening. (2020) Alterations in Tau Metabolism in ALS and ALS-FTSD. Frontiers in Neurology 11.
Crossref
Crossref
Manuel Perez, Imanol Amayra, Esther Lazaro, Maitane García, Oscar Martínez, Patricia Caballero, Sarah Berrocoso, Juan Francisco López-Paz, Mohammad Al-Rashaida, Alicia Aurora Rodríguez, Paula Luna & Luis Varona. (2020) Intrusion errors during verbal fluency task in amyotrophic lateral sclerosis. PLOS ONE 15:5, pages e0233349.
Crossref
Crossref
Rebekah M. AhmedEmma M. DevenneyCherie Strikwerda-BrownJohn R. HodgesOlivier Piguet & Matthew C. Kiernan. (2020) Phenotypic variability in ALS-FTD and effect on survival. Neurology 94:19.
Crossref
Crossref
Jose Luis Díaz, Helena Mondragón, Jesús Sancho, Eduardo J. Aguilar & Emilio Servera. (2019) Relationship Between Cognitive-Behavioral Impairment and Clinical and Functional Parameters in ALS and Reliability of the Edinburgh Cognitive and Behavioural ALS Screen to Assess ALS: Preliminary Findings. Cognitive and Behavioral Neurology 32:3, pages 185-192.
Crossref
Crossref
Laura M. Taylor, Pamela J. McMillan, Brian C. Kraemer & Nicole F. Liachko. (2019) Tau tubulin kinases in proteinopathy. The FEBS Journal 286:13, pages 2434-2446.
Crossref
Crossref
Rebekah M. Ahmed, Katherine Phan, Elizabeth Highton‐Williamson, Cherie Strikwerda‐Brown, Jashelle Caga, Eleanor Ramsey, Margaret Zoing, Emma Devenney, Woojin S. Kim, John R. Hodges, Olivier Piguet, Glenda M. Halliday & Matthew C. Kiernan. (2019) Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia. Annals of Clinical and Translational Neurology 6:3, pages 486-495.
Crossref
Crossref
Barry W. Festoff & Bruce A. Citron. (2019) Thrombin and the Coag-Inflammatory Nexus in Neurotrauma, ALS, and Other Neurodegenerative Disorders. Frontiers in Neurology 10.
Crossref
Crossref
Katherine S. Yanagi, Zhijin Wu, Joshua Amaya, Natalie Chapkis, Amanda M. Duffy, Kaitlyn H. Hajdarovic, Aaron Held, Arjun D. Mathur, Kathryn Russo, Veronica H. Ryan, Beatrice L. Steinert, Joshua P. Whitt, Justin R. Fallon, Nicolas L. Fawzi, Diane Lipscombe, Robert A. Reenan, Kristi A. Wharton & Anne C. Hart. (2019) Meta-analysis of Genetic Modifiers Reveals Candidate Dysregulated Pathways in Amyotrophic Lateral Sclerosis. Neuroscience 396, pages A3-A20.
Crossref
Crossref
Alexander J. Moszczynski, Matthew A. Hintermayer & Michael J. Strong. (2018) Phosphorylation of Threonine 175 Tau in the Induction of Tau Pathology in Amyotrophic Lateral Sclerosis—Frontotemporal Spectrum Disorder (ALS-FTSD). A Review. Frontiers in Neuroscience 12.
Crossref
Crossref
Rebekah M. Ahmed, Elizabeth Highton-Williamson, Jashelle Caga, Nicolette Thornton, Eleanor Ramsey, Margaret Zoing, Woojin Scott Kim, Glenda M. Halliday, Olivier Piguet, John R. Hodges, I. Sadaf Farooqi & Matthew C. Kiernan. (2017) Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition. Journal of Alzheimer's Disease 61:2, pages 773-783.
Crossref
Crossref
Meredith BockY.-Nhy DuongAnthony KimIsabel AllenJennifer MurphyCatherine Lomen-Hoerth. (2017) Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis. Neurology Clinical Practice 7:6, pages 488-498.
Crossref
Crossref
Rajka M. Liscic. (2017) Als and Ftd: Insights into the disease mechanisms and therapeutic targets. European Journal of Pharmacology 817, pages 2-6.
Crossref
Crossref
Caroline Seer, Max Joop, Florian Lange, Christian Lange, Reinhard Dengler, Susanne Petri & Bruno Kopp. (2017) Attenuated error-related potentials in amyotrophic lateral sclerosis with executive dysfunctions. Clinical Neurophysiology 128:8, pages 1496-1503.
Crossref
Crossref
Dennis Dimond, Abdullah Ishaque, Sneha Chenji, Dennell Mah, Zhang Chen, Peter Seres, Christian Beaulieu & Sanjay Kalra. (2017) White matter structural network abnormalities underlie executive dysfunction in amyotrophic lateral sclerosis. Human Brain Mapping 38:3, pages 1249-1268.
Crossref
Crossref
Sarah Martin, Ahmad Al Khleifat & Ammar Al-Chalabi. (2017) What causes amyotrophic lateral sclerosis?. F1000Research 6, pages 371.
Crossref
Crossref
A.J. Moszczynski & M.J. Strong. 2017. The Cerebral Cortex in Neurodegenerative and Neuropsychiatric Disorders. The Cerebral Cortex in Neurodegenerative and Neuropsychiatric Disorders
223
242
.
Shangxi Xiao, Laura MacNair, Jesse McLean, Phillip McGoldrick, Paul McKeever, Serena Soleimani, Julia Keith, Lorne Zinman, Ekaterina Rogaeva & Janice Robertson. (2016) C9orf72 isoforms in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration. Brain Research 1647, pages 43-49.
Crossref
Crossref
R. M. Ahmed, J. Caga, E. Devenney, S. Hsieh, L. Bartley, E. Highton-Williamson, E. Ramsey, M. Zoing, G. M. Halliday, O. Piguet, J. R. Hodges & M. C. Kiernan. (2016) Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival. Journal of Neurology 263:8, pages 1593-1603.
Crossref
Crossref
Mónica Zufiría, Francisco Javier Gil-Bea, Roberto Fernández-Torrón, Juan José Poza, Jose Luis Muñoz-Blanco, Ricard Rojas-García, Javier Riancho & Adolfo López de Munain. (2016) ALS: A bucket of genes, environment, metabolism and unknown ingredients. Progress in Neurobiology 142, pages 104-129.
Crossref
Crossref
Rebekah M Ahmed, Muireann Irish, Olivier Piguet, Glenda M Halliday, Lars M Ittner, Sadaf Farooqi, John R Hodges & Matthew C Kiernan. (2016) Amyotrophic lateral sclerosis and frontotemporal dementia: distinct and overlapping changes in eating behaviour and metabolism. The Lancet Neurology 15:3, pages 332-342.
Crossref
Crossref
A. V. Pronin, I. V. Gogoleva, I. Yu. Torshin & O. A. Gromovа. (2016) Neurotrophic effects of lithium stimulate the reduction of ischemic and neurodegenerative brain damage. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 116:2, pages 99.
Crossref
Crossref
Andreas Nidos, Dimitrios S. Kasselimis, Panagiotis G. Simos, Michael Rentzos, Theodoros Alexakis, Ioannis Zalonis, Vassiliki Zouvelou, Constantin Potagas, Ioannis Evdokimidis & Susan C. Woolley. (2016) Frontotemporal Dysfunction in Amyotrophic Lateral Sclerosis: A Discriminant Function Analysis. Neurodegenerative Diseases 16:3-4, pages 140-146.
Crossref
Crossref
Rajka M. Liščić. (2015) Molecular basis of ALS and FTD: implications for translational studies / Molekularna osnova ALS-a i FTD-a: implikacije za translacijska istraživanja. Archives of Industrial Hygiene and Toxicology 66:4, pages 285-290.
Crossref
Crossref
Paola Caroppo, Agnès Camuzat, Anne De Septenville, Philippe Couratier, Lucette Lacomblez, Sophie Auriacombe, Olivier Flabeau, Ludmila Jornéa, Frederic Blanc, François Sellal, Benjamin Cretin, Vincent Meininger, Marie‐Céline Fleury, Philippe Couarch, Bruno Dubois, Alexis Brice & Isabelle Le Ber. (2015)
Semantic and nonfluent aphasic variants, secondarily associated with amyotrophic lateral sclerosis, are predominant frontotemporal lobar degeneration phenotypes in
TBK1
carriers
. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 1:4, pages 481-486.
Crossref
Crossref
Andrew Eisen, Roger Lemon, Matthew C. Kiernan, Michael Hornberger & Martin R. Turner. (2015) Does dysfunction of the mirror neuron system contribute to symptoms in amyotrophic lateral sclerosis?. Clinical Neurophysiology 126:7, pages 1288-1294.
Crossref
Crossref
Jeffrey Rosenfeld & Michael J. Strong. (2015) Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease. Neurotherapeutics 12:2, pages 317-325.
Crossref
Crossref
Adeline S.L. Ng, Rosa Rademakers & Bruce L. Miller. (2015) Frontotemporal dementia: a bridge between dementia and neuromuscular disease. Annals of the New York Academy of Sciences 1338:1, pages 71-93.
Crossref
Crossref
Duo Zhang, Shuang Jiang & Heng Meng. (2015) Role of the Insulin-Like Growth Factor Type 1 Receptor in the Pathogenesis of Diabetic Encephalopathy. International Journal of Endocrinology 2015, pages 1-9.
Crossref
Crossref
R. M. Ahmed, E. Mioshi, J. Caga, M. Shibata, M. Zoing, L. Bartley, O. Piguet, J. R. Hodges & M. C. Kiernan. (2014) Body mass index delineates ALS from FTD: implications for metabolic health. Journal of Neurology 261:9, pages 1774-1780.
Crossref
Crossref
O. V. Forlenza, V. J. R. De-Paula & B. S. O. Diniz. (2014) Neuroprotective Effects of Lithium: Implications for the Treatment of Alzheimer’s Disease and Related Neurodegenerative Disorders. ACS Chemical Neuroscience 5:6, pages 443-450.
Crossref
Crossref
Richard A. Osborne, Ramnik Sekhon, Wendy Johnston & Sanjay Kalra. (2014) Screening for frontal lobe and general cognitive impairment in patients with amyotrophic lateral sclerosis. Journal of the Neurological Sciences 336:1-2, pages 191-196.
Crossref
Crossref
Emma Devenney & John Hodges. 2014. Movement Disorders in Dementias. Movement Disorders in Dementias
141
153
.
Johnathan Cooper-Knock, Thomas Jenkins & Pamela J. Shaw. (2013) Clinical and Molecular Aspects of Motor Neuron Disease. Colloquium Series on Genomic and Molecular Medicine 2:2, pages 1-60.
Crossref
Crossref
Yan Jouroukhin, Regina Ostritsky, Yaniv Assaf, Galit Pelled, Eliezer Giladi & Illana Gozes. (2013) NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: Protection against impairments in axonal transport. Neurobiology of Disease 56, pages 79-94.
Crossref
Crossref
Joel A. Cassel & Allen B. Reitz. (2013) Ubiquilin-2 (UBQLN2) binds with high affinity to the C-terminal region of TDP-43 and modulates TDP-43 levels in H4 cells: Characterization of inhibition by nucleic acids and 4-aminoquinolines. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1834:6, pages 964-971.
Crossref
Crossref
Serena Lattante, Guy A. Rouleau & Edor Kabashi. (2013)
TARDBP
and
FUS
Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update
. Human Mutation 34:6, pages 812-826.
Crossref
Crossref
Michael Benatar, Joanne Wuu & John Ravits. (2013) Opportunity and innovation in studying pre‐symptomatic amyotrophic lateral sclerosis. Muscle & Nerve 47:5, pages 629-631.
Crossref
Crossref
K. Witt, G. Deuschl & T. Bartsch. (2012) Frontotemporale DemenzenFrontotemporal dementias. Der Nervenarzt 84:1, pages 20-32.
Crossref
Crossref
K. Witt. 2013. Gedächtnisstörungen. Gedächtnisstörungen
204
218
.
Brian A. Keller, Kathryn Volkening, Cristian A. Droppelmann, Lee Cyn Ang, Rosa Rademakers & Michael J. Strong. (2012) Co-aggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism. Acta Neuropathologica 124:5, pages 733-747.
Crossref
Crossref
Joel A. Cassel, Mark E. McDonnell, Venkata Velvadapu, Vyacheslav Andrianov & Allen B. Reitz. (2012) Characterization of a series of 4-aminoquinolines that stimulate caspase-7 mediated cleavage of TDP-43 and inhibit its function. Biochimie 94:9, pages 1974-1981.
Crossref
Crossref
Cinzia Gellera, Nicola Ticozzi, Viviana Pensato, Lorenzo Nanetti, Alessia Castucci, Barbara Castellotti, Giuseppe Lauria, Franco Taroni, Vincenzo Silani & Caterina Mariotti. (2012) ATAXIN2 CAG-repeat length in Italian patients with amyotrophic lateral sclerosis: risk factor or variant phenotype? Implication for genetic testing and counseling. Neurobiology of Aging 33:8, pages 1847.e15-1847.e21.
Crossref
Crossref
Claire Flaherty-CraigAllyson Brothers, Ashley McFalls, Chengwu Yang & Zachary Simmons. (2012)
VALUES
†
: a national multicenter study of regional and gender differences in frontotemporal disease in amyotrophic lateral sclerosis
. Neurodegenerative Disease Management 2:3, pages 325-336.
Crossref
Crossref
I. Zalonis, F. Christidi, G. Paraskevas, T. Zabelis, I. Evdokimidis & E. Kararizou. (2012) Can Executive Cognitive Measures Differentiate Between Patients with Spinal- and Bulbar-Onset Amyotrophic Lateral Sclerosis?. Archives of Clinical Neuropsychology 27:3, pages 348-354.
Crossref
Crossref
J. S. Snowden, S. Rollinson, J. C. Thompson, J. M. Harris, C. L. Stopford, A. M. T. Richardson, M. Jones, A. Gerhard, Y. S. Davidson, A. Robinson, L. Gibbons, Q. Hu, D. DuPlessis, D. Neary, D. M. A. Mann & S. M. Pickering-Brown. (2012) Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135:3, pages 693-708.
Crossref
Crossref
Kai Y Soo, Manal Farg & Julie D. Atkin. (2011) Molecular Motor Proteins and Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 12:12, pages 9057-9082.
Crossref
Crossref
F. Geser, D. Prvulovic, L. O’Dwyer, O. Hardiman, P. Bede, A.L.W. Bokde, J.Q. Trojanowski & H. Hampel. (2011) On the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia. Progress in Neurobiology 95:4, pages 649-662.
Crossref
Crossref
L. H. Goldstein, I. C. Newsom-Davis, V. Bryant, M. Brammer, P. N. Leigh & A. Simmons. (2011) Altered patterns of cortical activation in ALS patients during attention and cognitive response inhibition tasks. Journal of Neurology 258:12, pages 2186-2198.
Crossref
Crossref
Orla Hardiman, Leonard H. van den Berg & Matthew C. Kiernan. (2011) Clinical diagnosis and management of amyotrophic lateral sclerosis. Nature Reviews Neurology 7:11, pages 639-649.
Crossref
Crossref
Michael Joseph Strong & Wencheng Yang. (2011) The Frontotemporal Syndromes of ALS. Clinicopathological Correlates. Journal of Molecular Neuroscience 45:3, pages 648-655.
Crossref
Crossref
Michael J. Strong & Kathryn Volkening. (2011) TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?. FEBS Journal 278:19, pages 3569-3577.
Crossref
Crossref
Michael J. Strong, Tibor Hortobágyi, Koichi Okamoto & Shinsuke Kato. 2011. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders
418
433
.
Masashi Tsujimoto, Jo Senda, Tetsuro Ishihara, Yoshiki Niimi, Yoshinari Kawai, Naoki Atsuta, Hirohisa Watanabe, Fumiaki Tanaka, Shinji Naganawa & Gen Sobue. (2011) Behavioral changes in early ALS correlate with voxel-based morphometry and diffusion tensor imaging. Journal of the Neurological Sciences 307:1-2, pages 34-40.
Crossref
Crossref
Mamede de Carvalho. (2011) Deep thoughts in ALS. Clinical Neurophysiology 122:5, pages 854-855.
Crossref
Crossref
Shahul Hameed, Ian R. A. Mackenzie & Ging-Yuek Robin Hsiung. 2011. Case Studies in Dementia. Case Studies in Dementia
90
97
.
M. ElaminJ. PhukanP. BedeN. JordanS. ByrneN. PenderO. Hardiman. (2011) Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 76:14, pages 1263-1269.
Crossref
Crossref
P. Hande Özdinler, Susanna Benn, Ted H. Yamamoto, Mine Güzel, Robert H. BrownJrJr & Jeffrey D. Macklis. (2011)
Corticospinal Motor Neurons and Related Subcerebral Projection Neurons Undergo Early and Specific Neurodegeneration in hSOD1
G93A
Transgenic ALS Mice
. The Journal of Neuroscience 31:11, pages 4166-4177.
Crossref
Crossref
N. Sudharshan, C. Hanstock, B. Hui, T. Pyra, W. Johnston & S. Kalra. (2011) Degeneration of the Mid-Cingulate Cortex in Amyotrophic Lateral Sclerosis Detected In Vivo with MR Spectroscopy. American Journal of Neuroradiology 32:2, pages 403-407.
Crossref
Crossref
Paul H. Gordon. (2011) Amyotrophic Lateral Sclerosis. CNS Drugs 25:1, pages 1-15.
Crossref
Crossref
Luc Dupuis, Pierre-François Pradat, Albert C Ludolph & Jean-Philippe Loeffler. (2011) Energy metabolism in amyotrophic lateral sclerosis. The Lancet Neurology 10:1, pages 75-82.
Crossref
Crossref
Peter Bede, Dominic Ó Brannagáin, Stefan Lorenzl, David J. Oliver & Orla Hardiman. 2011. Neurodegenerative Disorders. Neurodegenerative Disorders
263
289
.
Han-Jou Chen, Georgia Anagnostou, Andrea Chai, James Withers, Alex Morris, Jason Adhikaree, Giuseppa Pennetta & Jackie S. de Belleroche. (2010) Characterization of the Properties of a Novel Mutation in VAPB in Familial Amyotrophic Lateral Sclerosis. Journal of Biological Chemistry 285:51, pages 40266-40281.
Crossref
Crossref
Russell Lewis McLaughlin, Julie Phukan, William McCormack, David S. Lynch, Matthew Greenway, Simon Cronin, Jean Saunders, Agnieska Slowik, Barbara Tomik, Peter M. Andersen, Daniel G. Bradley, Phil Jakeman & Orla Hardiman. (2010) Angiogenin Levels and ANG Genotypes: Dysregulation in Amyotrophic Lateral Sclerosis. PLoS ONE 5:11, pages e15402.
Crossref
Crossref
A. Raggi & R. Ferri. (2010) Sleep disorders in neurodegenerative diseases. European Journal of Neurology 17:11, pages 1326-1338.
Crossref
Crossref
Luc Dupuis, Odile Spreux-Varoquaux, Gilbert Bensimon, Philippe Jullien, Lucette Lacomblez, François Salachas, Gaëlle Bruneteau, Pierre-François Pradat, Jean-Philippe Loeffler & Vincent Meininger. (2010) Platelet Serotonin Level Predicts Survival in Amyotrophic Lateral Sclerosis. PLoS ONE 5:10, pages e13346.
Crossref
Crossref
Joel A. Cassel, Benjamin E. Blass, Allen B. Reitz & Aaron C. Pawlyk. (2010) Development of a Novel Nonradiometric Assay for Nucleic Acid Binding to TDP-43 Suitable for High-Throughput Screening Using AlphaScreen® Technology. SLAS Discovery 15:9, pages 1099-1106.
Crossref
Crossref
Chris Gibbons & Erin Beneteau. (2010) Functional Performance Using Eye Control and Single Switch Scanning by People With ALS. Perspectives on Augmentative and Alternative Communication 19:3, pages 64-69.
Crossref
Crossref
Lili C. Kudo, Liubov Parfenova, Nancy Vi, Kimbley Lau, Justine Pomakian, Paul Valdmanis, Guy A. Rouleau, Harry V. Vinters, Martina Wiedau-Pazos & Stanislav L. Karsten. (2010) Integrative gene–tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis. Human Molecular Genetics 19:16, pages 3233-3253.
Crossref
Crossref
Dirk Bäumer, Olaf Ansorge, Mara Almeida & Kevin Talbot. (2010) The role of RNA processing in the pathogenesis of motor neuron degeneration. Expert Reviews in Molecular Medicine 12.
Crossref
Crossref
Felix Geser, Virginia M.-Y. Lee & John Q. Trojanowski. (2010) Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: A spectrum of TDP-43 proteinopathies. Neuropathology 30:2, pages 103-112.
Crossref
Crossref
M. Masellis, L. Zinman & S. E. Black. (2009) More than just ‘frontal’: disentangling behavioural disturbances in amyotrophic lateral sclerosis. European Journal of Neurology 17:1, pages 5-7.
Crossref
Crossref
Michael J. Strong. (2010) The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS). Journal of the Neurological Sciences 288:1-2, pages 1-12.
Crossref
Crossref
Felix Geser, Maria Martinez-Lage, Linda K. Kwong, Virginia M.-Y. Lee & John Q. Trojanowski. (2009) Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. Journal of Neurology 256:8, pages 1205-1214.
Crossref
Crossref
Livia Pasquali, Patrizia Longone, Ciro Isidoro, Stefano Ruggieri, Antonio Paparelli & Francesco Fornai. (2009) Autophagy, lithium, and amyotrophic lateral sclerosis. Muscle & Nerve 40:2, pages 173-194.
Crossref
Crossref
Andrew Eisen. (2009) Amyotrophic lateral sclerosis-Evolutionary and other perspectives. Muscle & Nerve 40:2, pages 297-304.
Crossref
Crossref
May Gohar, Wencheng Yang, Wendy Strong, Kathryn Volkening, Cheryl Leystra-Lantz & Michael J. Strong. (2009) Tau phosphorylation at threonine-175 leads to fibril formation and enhanced cell death: implications for amyotrophic lateral sclerosis with cognitive impairment. Journal of Neurochemistry 108:3, pages 634-643.
Crossref
Crossref
J. Phukan & O. Hardiman. (2009) The management of amyotrophic lateral sclerosis. Journal of Neurology 256:2, pages 176-186.
Crossref
Crossref